Imaging of esophageal cancer

1.Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin.2003; 53 :5–26. [PubMed]

2.Rankin S. Oesophageal cancer. In: Husband JES, Reznek RH, editors.Imaging in Oncology.Oxford: Isis Medical Media; 1998. pp. 93–110.

3.Castellsague X, Munoz N, De Stefani E, et al. Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int J Cancer.1999; 82 :657–64. [PubMed]

4.Blot WJ. Alcohol and cancer. Cancer Res.1992; 52 :2119s–23s. [PubMed]

5.Gore RM. Esophageal cancer: clinical and pathologic features. Radiol Clin North Am.1997; 35 :243–63. [PubMed]

6.Lukanich JM. Section I: epidemiological review. Semin Thorac Cardiovasc Surg.2003; 15 :158–66. [PubMed]

7.Meijssen MA, Tilanus HW, Van Blankenstein M, et al. Achalasia complicated by esophageal squamous cell carcinoma: a prospective study in 195 patients. Gut.1992; 33 :155–8. [PMC free article] [PubMed]

8.Shaheen N, Ransohoff DF. Gastroesophageal reflux, Barrett’s esophagus, and esophageal cancer: scientific review. J Am Med Assoc.2002; 287 :1972–81. [PubMed]

9.Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus. N Engl J Med.1985; 313 :857–9. [PubMed]

10.Drewitz DJ, Sampliner RE, Garewell HS. The incidence of adenocarcinoma in Barrett’s esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol.1997; 92 :212–5. [PubMed]

11.Younes M, Henson DE, Ertan A, Miller CC. Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histologic type. Scand J Gastroenterol.2002; 37 :1359–65. [PubMed]

12.Levine MS, Chu P, Furth EE, et al. Carcinoma of the esophagus and esophagogastric junction: sensitivity of radiographic diagnosis. AJR Am J Roentgenol.1997; 168 :1423–6. [PubMed]

13.Gupta S, Levine MS, Rubesin SE, Katzka DA, Laufer I. Usefulness of barium studies for differentiating benign and malignant strictures of the esophagus. AJR Am J Roentgenol.2003; 180 :737–44. [PubMed]

14.Levine MS. Esophageal cancer radiologic diagnosis. Radiol Clin North Am.1997; 35 :265–79. [PubMed]

15.Ueyema T, Kawamoto K, Yamada Y, Masuda K. Early esophageal carcinoma. Evaluation of the depth of invasion based on double contrast esophagography. Acta Radiol.1998; 39 :133–7. [PubMed]

16.Kato H, Momma K, Yoshida M. Early esophageal cancer: radiologic estimation of invasion into the muscularis mucosae. Abdom Imaging.2003; 28 :464–9. [PubMed]

17.Glickman JN. Section II: pathology and pathologic staging of esophageal cancer. Semin Thorac Cardiovasc Surg.2003; 15 :167–79. [PubMed]

18.Sannohe Y, Hiratsuka R, Doki K. Lymph node metastases in cancer of the thoracic esophagus. Am J Surg.1981; 141 :216–8. [PubMed]

19.Saunders HS, Wolfman NT, Ott DJ. Esophageal cancer radiologic staging. Radiol Clin North Am.1997; 35 :281–94. [PubMed]

20.Rapp-Bernhardt U, Welte T, Budinger M, Bernhardt TM. Comparison of three-dimensional virtual endoscopy with bronchoscopy in patients with oesophageal carcinoma infiltrating the tracheobronchial tree. Br J Radiol.1998; 71 :1271–8. [PubMed]

21.Picus D, Balfe DM, Koehler RE, et al. Computed tomography in the staging of esophageal carcinoma. Radiology.1983; 146 :433–8. [PubMed]

22.Takashima S, Takeuchi N, Shiozaki H, et al. Carcinoma of the esophagus: CT vs MR imaging in determining resectability. AJR Am J Roentgenol.1991; 156 :297–302. [PubMed]

23.Botet JF, Lightdale CJ, Zauber AG, et al. Radiology.1991; 181 :419–25. [PubMed]

24.Romagnuolo J, Scott J, Hawes RH, et al. Helical CT versus EUS with fine needle aspiration

for celiac nodal assessment in patients with esophageal cancer. Gastrointest Endosc.2002; 55 :648–54. [PubMed]

25.Kato H, Miyazaki T, Nakajima M, et al. Sentinel lymph nodes with technetium-99m colloidal rhenium sulfide in patients with esophageal carcinoma. Cancer.2003; 98 :932–9. [PubMed]

26.Kelly S, Harris KM, Berry E, et al. A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut.2001; 49 :534–9. [PMC free article] [PubMed]

27.Kimmey MB, Martin RW, Haggitt RC, et al. Histologic correlates of gastrointestinal ultrasound images. Gastroenterology.1989; 96 :433–41. [PubMed]

28.Eloubeidei MA, Wallace MB, Reed CE, et al. The utility of EUS and EUS-guided fine needle aspiration in detecting celiac lymph node metastasis in patients with esophageal cancer: a single-center experience. Gastrointest Endosc.2001; 54 :714–9. [PubMed]

29.Mariette C, Balon JM, Maunoury V, et al. Value of endoscopic ultrasonography as a predictor of long-term survival in oesophageal carcinoma. Br J Surg.2003; 90 :1367–72. [PubMed]

30.Meltzer CC, Luketich JD, Friedman D, et al. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography. Clin Nucl Med.2000; 25 :882–7. [PubMed]

31.Choi JY, Lee KH, Shim YM, et al. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med.2000; 41 :808–15. [PubMed]

32.Kole AC, Plukker JT, Nieweg OE, Vaalburg W. Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer.1998; 78 :521–7. [PMC free article] [PubMed]

33.Flanagan FL, Dehdashti F, Siegel BA, et al. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol.1997; 168 :417–24. [PubMed]

34.Yoon YC, Lee KS, Shim YM, et al. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection—prospective study. Radiology.2003; 227 :764–70. [PubMed]

35.Kato H, Kuwanto H, Nakajima M, et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer.2002; 94 :921–8. [PubMed]

36.Linden PA, Sugarbaker DJ, Section V. Techniques of esophageal resection. Semin Thorac Cardiovasc Surg.2003; 15 :197–209. [PubMed]

37.Adelstein DJ, Rice TW, Tefft M, et al. Aggressive concurrent chemo-radiotherapy and surgical resection for proximal esophageal squamous cell carcinoma. Cancer.1994; 74 :1680–5. [PubMed]

38.Kukreja J, Jaklitsch MT. Section IV: selective use of neoadjuvant therapy. Semin Thorac Cardiovasc Surg.2003; 15 :187–96. [PubMed]

39.Carter R, Smith JS, Anderson JR. Laser recanalization versus endoscopic intubation in the palliation of malignant dysphagia: a randomized prospective study. Br J Surg.1992; 79 :1167–70. [PubMed]

40.Petrovich Z, Langholz B, Formenti S, et al. Management of carcinoma of the esophagus: the role of radiotherapy. Am J Clin Oncol.1991; 14 :80–6. [PubMed]

41.Stahl M, Wilke H, Fink U, et al. Combined pre-operative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol.1996; 14 :829–37. [PubMed]

42.Downey RJ, Akhurst T, Ilson D, et al. Whole body 18FDG PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol.2003; 21 :428–32. [PubMed]

43.Carlisle JG, Quint LE, Francis IR, et al. Recurrent esophageal carcinoma: CT evaluation after esophagectomy. Radiology.1993; 189 :271–5. [PubMed]

Category: Cancer-2

Similar articles: